443 related articles for article (PubMed ID: 19251820)
1. Functional characterization of the human organic cation transporter 2 variant p.270Ala>Ser.
Zolk O; Solbach TF; König J; Fromm MF
Drug Metab Dispos; 2009 Jun; 37(6):1312-8. PubMed ID: 19251820
[TBL] [Abstract][Full Text] [Related]
2. OCT2 polymorphisms and in-vivo renal functional consequence: studies with metformin and cimetidine.
Wang ZJ; Yin OQ; Tomlinson B; Chow MS
Pharmacogenet Genomics; 2008 Jul; 18(7):637-45. PubMed ID: 18551044
[TBL] [Abstract][Full Text] [Related]
3. Genetic variants of the organic cation transporter 2 influence the disposition of metformin.
Song IS; Shin HJ; Shim EJ; Jung IS; Kim WY; Shon JH; Shin JG
Clin Pharmacol Ther; 2008 Nov; 84(5):559-62. PubMed ID: 18401339
[TBL] [Abstract][Full Text] [Related]
4. Interaction of beta-blockers with the renal uptake transporter OCT2.
Bachmakov I; Glaeser H; Endress B; Mörl F; König J; Fromm MF
Diabetes Obes Metab; 2009 Nov; 11(11):1080-3. PubMed ID: 19740083
[TBL] [Abstract][Full Text] [Related]
5. Effect of genetic variation in the organic cation transporter 2 on the renal elimination of metformin.
Chen Y; Li S; Brown C; Cheatham S; Castro RA; Leabman MK; Urban TJ; Chen L; Yee SW; Choi JH; Huang Y; Brett CM; Burchard EG; Giacomini KM
Pharmacogenet Genomics; 2009 Jul; 19(7):497-504. PubMed ID: 19483665
[TBL] [Abstract][Full Text] [Related]
6. Functional characteristics and steroid hormone-mediated regulation of an organic cation transporter in Madin-Darby canine kidney cells.
Shu Y; Bello CL; Mangravite LM; Feng B; Giacomini KM
J Pharmacol Exp Ther; 2001 Oct; 299(1):392-8. PubMed ID: 11561104
[TBL] [Abstract][Full Text] [Related]
7. Agmatine is efficiently transported by non-neuronal monoamine transporters extraneuronal monoamine transporter (EMT) and organic cation transporter 2 (OCT2).
Gründemann D; Hahne C; Berkels R; Schömig E
J Pharmacol Exp Ther; 2003 Feb; 304(2):810-7. PubMed ID: 12538837
[TBL] [Abstract][Full Text] [Related]
8. Functional characteristics and membrane localization of rat multispecific organic cation transporters, OCT1 and OCT2, mediating tubular secretion of cationic drugs.
Urakami Y; Okuda M; Masuda S; Saito H; Inui KI
J Pharmacol Exp Ther; 1998 Nov; 287(2):800-5. PubMed ID: 9808712
[TBL] [Abstract][Full Text] [Related]
9. Relevance of the organic cation transporters 1 and 2 for antiretroviral drug therapy in human immunodeficiency virus infection.
Jung N; Lehmann C; Rubbert A; Knispel M; Hartmann P; van Lunzen J; Stellbrink HJ; Faetkenheuer G; Taubert D
Drug Metab Dispos; 2008 Aug; 36(8):1616-23. PubMed ID: 18490433
[TBL] [Abstract][Full Text] [Related]
10. Substrate-Dependent Inhibition of the Human Organic Cation Transporter OCT2: A Comparison of Metformin with Experimental Substrates.
Hacker K; Maas R; Kornhuber J; Fromm MF; Zolk O
PLoS One; 2015; 10(9):e0136451. PubMed ID: 26327616
[TBL] [Abstract][Full Text] [Related]
11. Transport of the dopamine D2 agonist pramipexole by rat organic cation transporters OCT1 and OCT2 in kidney.
Ishiguro N; Saito A; Yokoyama K; Morikawa M; Igarashi T; Tamai I
Drug Metab Dispos; 2005 Apr; 33(4):495-9. PubMed ID: 15640376
[TBL] [Abstract][Full Text] [Related]
12. Transporters as a determinant of drug clearance and tissue distribution.
Shitara Y; Horie T; Sugiyama Y
Eur J Pharm Sci; 2006 Apr; 27(5):425-46. PubMed ID: 16488580
[TBL] [Abstract][Full Text] [Related]
13. Organic cation transporter-mediated renal secretion of ipratropium and tiotropium in rats and humans.
Nakanishi T; Haruta T; Shirasaka Y; Tamai I
Drug Metab Dispos; 2011 Jan; 39(1):117-22. PubMed ID: 20962061
[TBL] [Abstract][Full Text] [Related]
14. Ablation of both organic cation transporter (OCT)1 and OCT2 alters metformin pharmacokinetics but has no effect on tissue drug exposure and pharmacodynamics.
Higgins JW; Bedwell DW; Zamek-Gliszczynski MJ
Drug Metab Dispos; 2012 Jun; 40(6):1170-7. PubMed ID: 22407892
[TBL] [Abstract][Full Text] [Related]
15. The organic cation transporters rOCT1 and hOCT2 are inhibited by cGMP.
Schlatter E; Mönnich V; Cetinkaya I; Mehrens T; Ciarimboli G; Hirsch JR; Popp C; Koepsell H
J Membr Biol; 2002 Oct; 189(3):237-44. PubMed ID: 12395288
[TBL] [Abstract][Full Text] [Related]
16. Pharmacogenetics meets metabolomics: discovery of tryptophan as a new endogenous OCT2 substrate related to metformin disposition.
Song IS; Lee DY; Shin MH; Kim H; Ahn YG; Park I; Kim KH; Kind T; Shin JG; Fiehn O; Liu KH
PLoS One; 2012; 7(5):e36637. PubMed ID: 22590580
[TBL] [Abstract][Full Text] [Related]
17. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
18. The variant organic cation transporter 2 (OCT2)-T201M contribute to changes in insulin resistance in patients with type 2 diabetes treated with metformin.
Kashi Z; Masoumi P; Mahrooz A; Hashemi-Soteh MB; Bahar A; Alizadeh A
Diabetes Res Clin Pract; 2015 Apr; 108(1):78-83. PubMed ID: 25662675
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide down-regulates the expression of organic cation transporters (OCT) 1 and 2 in rat kidney during endotoxemia.
Heemskerk S; Wouterse AC; Russel FG; Masereeuw R
Eur J Pharmacol; 2008 Apr; 584(2-3):390-7. PubMed ID: 18313662
[TBL] [Abstract][Full Text] [Related]
20. Organic cation transporters OCT1, 2, and 3 mediate high-affinity transport of the mutagenic vital dye ethidium in the kidney proximal tubule.
Lee WK; Reichold M; Edemir B; Ciarimboli G; Warth R; Koepsell H; Thévenod F
Am J Physiol Renal Physiol; 2009 Jun; 296(6):F1504-13. PubMed ID: 19357179
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
